🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Combined Effects of NMES and LIRT on Muscle Strength, Girth, and Physical Endurance in the Geriatric Population

RecruitingNAAges 65 Years - 85 YearsAllRiphah International University
NCT07646405 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will employ a randomized controlled trial design with a pre-post design to investigate the combined effects of Neuromuscular Electrical Stimulation (NMES) and Low-Intensity Resistance Training (LIRT) on muscle strength, muscle girth, and physical endurance in the geriatric population. Participants will be randomly assigned to either an intervention group or a control group.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria:• Age: 65 to 85 (35) * Both male and female will be added(29) * Patients with low calf muscle mass \<31.5 cm for females and \<33.5 cm for males will be included in this study(36). * Participants able to complete the Five Times Sit-to-Stand Test in ≤ 10 seconds (men) or ≤ 11 seconds (women)(37). * Participants must have ability to walk independently and absence of severe medical conditions(29). * Participants who takes \> 12 seconds to complete TUG will be included in this study(38 Exclusion Criteria:• Participants with contraindications to NMES or RT, such as pacemakers or severe cardiovascular disease(29). * Participants with a MoCA score of less than 26 will be excluded to ensure adequate cognitive ability to comprehend and follow the study protocol, including exercise and neuromuscular stimulation procedures (39). * Participants with any musculoskeletal issues will be excluded from this study(35). * Participants with neuromuscular disorders that may affect muscle strength or function(29).
💊

What it tests

  • Neuromuscular electrical stimulation
  • lOW intensity resistance training
📍

Where

1 site
—
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy